Table 2 Detection of persistent low avidity HPV16 or HPV18 antibodies at month 7 stratified by smoking status
Low avidity (= < 40%) | High avidity (>40%) | OR, 95% CI | |
|---|---|---|---|
HPV16 | |||
Non-smokers (n = 55) | 4 (31%) | 51 (57%) | 1 |
Smokers (n = 48) | 9 (69%) | 39 (43%) | 2.9 (0.8-10.3) |
HPV18 | |||
Non-smokers (n = 55) | 1 (33%) | 54 (54%) | 1 |
Smokers (n = 48) | 2 (67%) | 46 (46%) | 2.8 (0.2-31.6) |
HPV16/18 | |||
Non-smokers (n = 55) | 5 (31%) | 50 (57%) | 1 |
Smokers (n = 48) | 11 (69%) | 37 (43%) | 3.0 (1.0*-9.3) |